nausea%20-and-%20vomiting%20in%20pregnancy
NAUSEA & VOMITING IN PREGNANCY
Nausea & vomiting in pregnancy (NVP), commonly known as "morning sickness", affects 50-90% of pregnant women.
In most women, the condition manifests between the 4th-7th week after last menstrual period and resolves by the 16th week of gestation.
It manifests in a spectrum of severity from mild nausea to very rare life-threatening symptoms.
The etiology is multifactorial.
The pregnant woman's sense of well-being and her daily activities are greatly affected by nausea and vomiting; the physical and emotional impact often leads to anxiety and worry about the effect of the symptoms on the fetus and reduced job efficiency.

Supportive Therapy

Consider inpatient treatment for pregnant patients with the following:

  • Persistently abnormal vital signs
  • Severe dehydration unable to tolerate oral fluids
  • Severe electrolyte abnormality and acidosis
  • Malnutrition
  • Presence of infection and unable to tolerate oral antibiotics
  • Inability to take oral antiemetics

Supportive Measures

Rehydration

  • Warranted when dehydration, electrolyte abnormalities, or acid-base disturbances are demonstrated
  • Intravenous (IV) Fluids
    • Normal saline or Ringer’s lactate, maintain urine output to >100 mL/hour
    • Urea and serum electrolyte levels should be monitored while on IV fluids
  • Correction of electrolyte imbalance including magnesium, calcium, potassium, and phosphorus
  • Multivitamin IV supplementation especially thiamine to prevent Wernicke’s encephalopathy

Enteral (EN) or Parenteral Nutrition (PN)

  • As a last resort measure and monitored in centers with the ability to provide home parenteral therapy
  • Indicated for patients with persistent weight loss despite use of noninvasive therapies
  • EN should be initiated as a slow, continuous, isotonic infusion
  • PN is used when EN is not tolerated
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
14 Oct 2017
In pregnant women, adherence to recommended dietary intake of fat and fibre is associated with a more beneficial and richer gut microbiota which, in turn, decreases levels of the inflammation marker glycoprotein acetylation (GlycA), a study has shown.
5 days ago
Elagolix is safe and effective for reducing heavy menstrual bleeding in females with fibroids, a new dose-ranging, multiple-cohort study has shown.
13 Oct 2017
Dr Joon Kiong Lee discusses pharmacotherapy for osteoporosis and the role of FLS in fracture prevention
Tristan Manalac, 06 Oct 2017
In women with polycystic ovary syndrome (PCOS), combined oral contraceptive (COC) with spironolactone is more effective than metformin in reducing symptoms while showing a similar safety profile, according to a new randomized clinical trial (RCT).